Sylvie Legrain

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue

Etienne-Emile Baulieu, Guy Thomas, Sylvie Legrain et al. · Proceedings of the National Academy of Sciences · 2000 · 580 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Amnestic syndrome of the medial temporal type identifies prodromal AD

Marie Sarazin, Claudine Berr, Jocelyne de Rotrou et al. · Neurology · 2007 · 460 citations

Medicine, Neurology, Psychology +17

Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease

Philippe Robert, Claudine Berr, Magali Volteau et al. · Clinical Neurology and Neurosurgery · 2006 · 181 citations

Medicine, Geriatric Medicine, Neurology +12

Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study

Nathalie Lechevallier‐Michel, Marion Gautier-Bertrand, Annick Alp�rovitch et al. · European Journal of Clinical Pharmacology · 2004 · 138 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +15

Serum dehydroepiandrosterone sulfate levels as an individual marker.

G. Neil Thomas, N Frénoy, Sylvie Legrain et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 134 citations

Medicine, Endocrinology, Geriatric Medicine +15